Skip to main content
MDGL logo

MDGL · Madrigal Pharmaceuticals, Inc. · Share Buybacks

Track MDGL — free
$421.99 -1.97 (-0.46%) At close · Nov 17 Play latest call Q3 2026 earnings call transcript
Market Cap
$9.80B
Shares
23.23M
Volume · Nov 17 364.74K Avg daily vol (3M) 358.96K

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Equity Offering (ATM) Programs

Program Established Capacity Remaining Runs Through
2024-05 $300,000,000 $300,000,000 as of 2026-09-30 —

Repurchase History

Fiscal Year Ended Cash Spent
2012-12-31 $32,000
Key facts CIK 1157601 CUSIP 558868105 13F (30d) 453 filings 415 filers Visit website Investor relations